European guidelines on cardiovascular disease prevention: What has changed in 2012?;Europäische Leitlinien zur Prävention kardiovaskulärer Erkrankungen: Was hat sich 2012 geändert?

Herz

Volumn 38, Issue 8, 2013, Pages 838-847

  Gohlke, H ^a  

^a NONE   (Germany)

Author keywords

Antiplatelet therapy; Lifestyle modification; Lipids; Primary prevention; Risk stratification; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BEHAVIOR CHANGE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; EUROPE; HYPERTENSION; LIFESTYLE MODIFICATION; MEDITERRANEAN DIET; MORTALITY; MOTIVATIONAL INTERVIEWING; PASSIVE SMOKING; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIMARY PREVENTION; SECONDARY PREVENTION; SMOKING CESSATION;

CARDIOLOGY; CARDIOVASCULAR DISEASES; EUROPE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREVENTIVE MEDICINE; PRIMARY PREVENTION; RISK REDUCTION BEHAVIOR;

EID: 84891273842     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-013-3974-0     Document Type: Article

References (18)

1. http://www.gbe-bund.de/gbe10/trecherche.prc-them-rech?tk=8500&tk2= 8700&p-uid=gast&p-aid=41651818&p-sprache=D&cnt-ut=6&ut=8700, zugegriffen: 19. September 2013
2. Gaber E, Wildner M (2011) Gesundheitsberichterstattung des Bundes, Heft 52: Sterblichkeit, Todesursachen und regionale Unterschiede. http://www.gbe-bund.de/gbe10/ergebnisse.prc-tab?fid=13932&suchstring= &query-id=&sprache=D&fund-typ=TXT&methode=&vt= &verwandte=1&page-ret=0&seite=1&p-lfd-nr=2&p-news= &p-sprachkz=D&p-uid=gast&p-aid=41651818&hlp-nr=2&p-janein=J, zugegriffen: 19. September 2013
3. Heidenreich PA, Trogdon JG, Khavjou OA et al (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123:933-944
4. Perk J, De Backer G, Gohlke H et al; European Association for Cardiovascular Prevention & Rehabilitation (EACPR) (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33:1635-701
5. Schuler GC, Koenig W, Adams V, Gohlke H (2013) Kommentar zu den neuen Leitlinien (2012) der Europäischen Gesellschaft für Kardiologie zur kardiovaskulären Prävention. Kardiologe 7:251-260
6. Gohlke H, Albus C, Gysan DB et al (2009) Cardiovascular prevention in clinical practice (ESC and German Guidelines 2007). Herz 34:4-14
7. Gohlke H (2012) Primärprävention der koronaren Herzerkrankung-Was nützen die Risiko-Scores? Herz 37:75-80
8. Mons U (2011) Tabakattributable Mortalität in Deutschland und in den deutschen Bundesländern-Berechnungen mit Daten des Mikrozensus und der Todesursachenstatistik. Gesundheitswesen 73:238-246
9. Heatherton TF, Koziowski LT, Frecker RC, Fagerström KO (1991) The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86:1119-1127
10. Tan CE, Glantz SA (2012) Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: a meta-analysis. Circulation 126:2177-2183
11. Wen CP, Wai JP, Tsai MK et al (2011) Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 378:1244-1253
12. Estruch R, Ros E, Salas-Salvadó J et al (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368:1279-1290
13. Klaus D, Hoyer J, Middeke M (2010) Kochsalzrestriktion zur Prävention kardiovaskulärer Erkrankungen. Dtsch Ärztebl Int 107(26):457-462
14. Prospective Studies Collaboration, Whitlock G, Lewington S (2009) Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet 373:1083-1096
15. Villareal DT, Chode S, Parimi N et al (2011) Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med 364:1218-1229
16. De Berardis G, Sacco M, Strippoli GF et al (2009) Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ 339:b4531
17. Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373:1849-1860
18. Reiner Z, Catapano AL, De Backer G et al (2011) ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32:1769-1818